Viscosupplementation Market

Viscosupplementation Market (Product Type: Single Injection, Three Injections, and Five Injections; Application: Knee Osteoarthritis, Hip Osteoarthritis, and Hand Osteoarthritis; Source: Animal and Non-animal; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Viscosupplementation Reinvented with Biomimetic Polymers to Restore Mobility in OA Patients

An alarming number of individuals suffering from osteoarthritis (OA) has fueled innovation of next-gen viscosupplements. Companies in the viscosupplementation market are increasing efforts to deliver formulations that result in long-lasting pain relief. For instance, Articulate Biosciences— a pre-seed medical device startup, has gained expertise in the development of next-gen, cartilage-protecting viscosupplement that provides significantly longer pain relief to OA patients. The key to success in the market for viscosupplementation is longer pain relief and restoration of mobility in OA patients. Such innovations are bolstering market growth, where the market is estimated to reach a value of ~US$ 4.8 Bn by the end of 2027.

Novel biomimetic polymer viscosupplements are increasingly replacing in-development osteoarthritis joint injections. Hence, companies in the viscosupplementation market are increasing R&D in biocompatible polymers, since these polymers are extensively used in FDA-approved stents, contact lenses, and surgical meshes. The market is witnessing a change with the introduction of biocompatible polymers that prevent degradation associated with hyaluronic acid.

viscosupplementation market Infographic

To know the scope of our report Get a Sample on Viscosupplementation Market

Intra-articular Single-injection Viscosupplements Enter List of High-value Therapeutic Solutions

Innovations in intra-articular single-injection viscosupplements are generating revenue opportunities for healthcare companies. This is justified since the revenue of single-injection products is predicted to experience an uptick in the viscosupplementation market. Companies are developing viscosupplements that stay for a prolonged period in the knee joint cavity. For instance, Seikagaku Corporation— a Japan-based pharmaceutical company, announced the launch of HyLink®, a CE marked intra-articular single-injection viscosupplement used for the treatment of knee osteoarthritis through MDM S.p.A., a pharmaceutical company involved in active marketing of high-value therapeutic solutions in Italy. As such, the revenue of knee osteoarthritis application segment is projected for exponential growth in the viscosupplementation market.

Get a glimpse of the in-depth analysis through our Report Brochure

Companies in the market for viscosupplementation are increasing their research efforts in cross-linked hyaluronate hydrogel, which stays longer in the knee joint cavity and offers pain relief for prolonged weeks. Manufacturers in the market for viscosupplementation are setting their collaboration wheels in motion by entering into exclusive distributorship agreements to strategically target OA patients.

Consensus-based Expert Statements to Guide Practitioners on IAHA Implementation

The viscosupplementation market is projected to expand at a CAGR of ~7% during the forecast period. Since companies have established a strong business hold in North America, they are now turning toward Asia Pacific to unearth revenue streams, since this market in Asia Pacific is anticipated for aggressive growth. India being one of the rapidly growing economies of Asia Pacific, is grabbing the attention of healthcare companies and researchers to develop products through deep understanding of patients and clinician needs. However, it has been found that there is a dearth of robust evidence supporting the effectiveness of viscosupplementation or intra-articular hyaluronic acid (IAHA) treatment, which is likely to hamper market growth.

Nonoperative treatment approaches such as viscosupplementation and IAHA delay the need for total knee replacement surgeries in patients who are not ideal candidates for invasive treatment methods. However, the lack of clinical evidence on the safety and effectiveness of IAHA has created barriers for market growth in India. Thus, companies in the viscosupplementation market should increase efforts to collect consensus-based expert statements that can guide practitioners on IAHA use.

Combination Therapy of Gel Injection and Knee Bracing Benefit Moderate-grade Knee Arthritis Patients

Apart from knee OA, companies in the viscosupplementation market are seeking value growth by increasing treatment options for hip and hand OA. Manufacturers are increasing their production capabilities to develop innovative synovial fluids that thicken up when pressure is applied and act as shock absorbing materials. The growing availability of synthetic products are triggering the growth of the viscosupplementation market. This is evident since non-animal sourced products are anticipated for exponential growth in the market landscape.

Companies in the market for viscosupplementation are increasing awareness about combination treatments such as gel injections with knee bracing to improve patient outcomes. It has been found that gel injections may be more effective when combined with knee bracing. This combination treatment are benefitting patients with moderate-grade knee arthritis. Likewise, companies are increasing R&D activities to develop combination therapies using stem cell for patients with severe knee arthritis.

viscosupplementation market Segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Apart from retail pharmacies, companies in the viscosupplementation market are directing their supply chains toward online pharmacies, since this distribution channel is projected for aggressive growth during the forecast period. Companies are focusing on innovations in 3-injection regimens using sodium hyarulonate acid.

IAHA has helped to delay the need for total knee replacement surgeries in patients who are not ideal for surgical treatments. However, the lack of evidence on the safety and effectiveness of IAHA has slowed down market growth. Hence, companies should aim toward collecting consensus-based expert statements through government-held advisory board meetings that can guide practitioners on the IAHA use.

Viscosupplementation Market: Overview

  • Viscosupplement drugs can be administered using single injection, three injections, and five injections. These injections are used for arthritis for all types of joint.
  • In this procedure, a gel-like fluid called hyaluronic acid is injected into the joint
  • The three injections segment dominated the global viscosupplementation market in 2018. Growth of the segment can be attributed to increase in demand for viscosupplement injections and rise in adoption of this therapy.
  • Rise in prevalence of osteoarthritis among the geriatric population is a major factor boosting the growth of the global viscosupplementation market. The prevalence of osteoarthritis is high among the elderly population and increases with age. An article published by the Geriatric Orthopedic Surgery & Rehabilitation in 2015 stated that osteoarthritis (OA) is the most common age-related joint disease affecting over 80% people aged above 55.
  • Surge in demand for minimally invasive surgery is another factor fueling the growth of the global viscosupplementation market. Viscosupplement injection is a minimally invasive therapy for osteoarthritis, which minimizes blood loss, reduces hospital stay, offers quicker rehabilitation, and smaller incision. Rise in inclination toward minimally invasive surgery drives demand for viscosupplementation.

Rise in Awareness about New Drugs for Treatment

  • Rise in awareness about new drugs for treatment propels the global market. Knee osteoarthritis is a leading cause of disability among the geriatric population. Therapeutic options for knee OA include non-pharmacologic, pharmacologic, and surgical interventions. Joint replacement surgery is generally reserved for patients who do not respond to other treatments. An article published in NCBI in 2015 indicated that treatments considered to be most effective include viscosupplement injections (74.1%), narcotics (67.8%), and steroid injection (67.6%).

Market Segmentation: Viscosupplementation Market

  • Based on product type, the global viscosupplementation market has been divided into single injection, three injections, and five injections
  • In terms of application, the global viscosupplementation market has been classified into knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis
  • Based on source, the global viscosupplementation market has been bifurcated into animal and non-animal
  • In terms of distribution channel, the global viscosupplementation market has been categorized into retail pharmacies, hospital pharmacies, and online pharmacies
  • Each of the segments has been analyzed in detail for market trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027 along with market size estimations.

Geographic Overview: Viscosupplementation Market

  • In terms of region, the global viscosupplementation market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and future market sizes in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGRs for the period from 2019 to 2027
  • The study also offers a list of recommendations, highlights, and useful insights of the market which will help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process

Major Players

  • The report concludes with the company profiles section that includes key information about the major players in the market
  • Leading players analyzed in the report are 
    • Sanofi
    • Anika Therapeutics, Inc.
    • Seikagaku Corporation
    • Zimmer Biomet
    • Ferring B.V.
    • LG Chem
    • Chugai Pharmaceutical Co., Ltd,
    • Bioventus, Inc.
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Viscosupplementation Market - Segmentation

TMR’s study on the global viscosupplementation market includes information divided into five segments: product type, source, application, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global viscosupplementation market have been discussed in detail.

Product Type

Single Injection

Three Injections

Five Injections

Application

Knee Osteoarthritis

Hip Osteoarthritis

Hand Osteoarthritis

Source

Animal

Non-animal

Distribution Channel

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of viscosupplementation market?

Viscosupplementation market is estimated to reach a value of ~US$ 4.8 Bn by the end of 2027

What is the anticipated CAGR of the viscosupplementation market in the forecast period?

Viscosupplementation market is projected to expand at a CAGR of ~7% from 2019 to 2027

What are the key driving factors for the growth of the viscosupplementation market?

Viscosupplementation market is driven by rise in prevalence of osteoarthritis among the geriatric population

Which region is expected to project the highest market share in the global viscosupplementation market?

North America accounted for a major share of the global viscosupplementation market

Who are the key players in the viscosupplementation market?

Key players in the viscosupplementation market include Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Biomet, Ferring B.V.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Viscosupplementation Market

    4. Market Overview

        4.1.  Introduction & Overview

        4.2. Market Dynamics

            4.2.1. Drivers

            4.2.2. Restraints

            4.2.3. Opportunities 

        4.3. Porter’s Five Forces Analysis

        4.4. Global Viscosupplementation Market Analysis and Forecast, 2017–2027

    5. Market Outlook 

        5.1. Disease Prevalence & Incidence Rate globally with key countries 

        5.2. Key Industry Development 

    6. Global Viscosupplementation Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            6.2.1. Single Injection

            6.2.2. Three Injections

            6.2.3. Five Injections

        6.3. Global Viscosupplementation Market Attractiveness, by Product Type

    7. Global Viscosupplementation Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Global Viscosupplementation Market Value (US$) Forecast, by Application, 2017–2027

            7.2.1. Knee Osteoarthritis

            7.2.2. Hip Osteoarthritis

            7.2.3. Hand Osteoarthritis

        7.3. Global Viscosupplementation Market Attractiveness, by Application

    8. Global Viscosupplementation Market Analysis and Forecast, by Source

        8.1. Introduction & Definition

        8.2. Global Viscosupplementation Market Value (US$) Forecast, by Source, 2017–2027

            8.2.1. Animal

            8.2.2. Non-animal

        8.3. Global Viscosupplementation Market Attractiveness, by Source

    9. Global Viscosupplementation Market Analysis and Forecast, by Distribution Channel

        9.1. Introduction & Definition

        9.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            9.2.1. Hospital Pharmacies

            9.2.2. Retail Pharmacies

            9.2.3. Online Pharmacies

        9.3. Global Viscosupplementation Market Attractiveness, by Distribution Channel

    10. Global Viscosupplementation Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Global Viscosupplementation Market Attractiveness, by Region

    11. North America Viscosupplementation Market Analysis and Forecast

        11.1. Introduction

        11.2. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            11.2.1. Single Injection

            11.2.2. Three Injections

            11.2.3. Five Injections

        11.3. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

            11.3.1. Knee Osteoarthritis

            11.3.2. Hip Osteoarthritis

            11.3.3. Hand Osteoarthritis

        11.4. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

            11.4.1. Animal

            11.4.2. Non-animal

        11.5. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            11.5.1. Hospital Pharmacies

            11.5.2. Retail Pharmacies

            11.5.3. Online Pharmacies

        11.6. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.6.1. U.S.

            11.6.2. Canada

        11.7. North America Viscosupplementation Market Attractiveness Analysis

            11.7.1. By Product Type

            11.7.2. By Application

            11.7.3. By Source

            11.7.4. By Distribution Channel

            11.7.5. By Country 

    12. Europe Viscosupplementation Market Analysis and Forecast

        12.1. Introduction

        12.2. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            12.2.1. Single Injection

            12.2.2. Three Injections

            12.2.3. Five Injections

        12.3. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

            12.3.1. Knee Osteoarthritis

            12.3.2. Hip Osteoarthritis

            12.3.3. Hand Osteoarthritis

        12.4. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

            12.4.1. Animal

            12.4.2. Non-animal

        12.5. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            12.5.1. Hospital Pharmacies

            12.5.2. Retail Pharmacies

            12.5.3. Online Pharmacies

        12.6. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Europe Viscosupplementation Market Attractiveness Analysis

            12.7.1. By Product Type

            12.7.2. By Application

            12.7.3. By Source

            12.7.4. By Distribution Channel 

            12.7.5. By Country/Sub-region

    13. Asia Pacific Viscosupplementation Market Analysis and Forecast

        13.1. Introduction

        13.2. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            13.2.1. Single Injection

            13.2.2. Three Injections

            13.2.3. Five Injections

        13.3. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

            13.3.1. Knee Osteoarthritis

            13.3.2. Hip Osteoarthritis

            13.3.3. Hand Osteoarthritis

        13.4. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

            13.4.1. Animal

            13.4.2. Non-animal

        13.5. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            13.5.1. Hospital Pharmacies

            13.5.2. Retail Pharmacies

            13.5.3. Online Pharmacies

        13.6. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Asia Pacific Viscosupplementation Market Attractiveness Analysis

            13.7.1. By Product Type

            13.7.2. By Application

            13.7.3. By Source

            13.7.4. By Distribution Channel 

            13.7.5. By Country/Sub-region

    14. Latin America Viscosupplementation Market Analysis and Forecast

        14.1. Introduction

        14.2. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            14.2.1. Single Injection

            14.2.2. Three Injections

            14.2.3. Five Injections

        14.3. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

            14.3.1. Knee Osteoarthritis

            14.3.2. Hip Osteoarthritis

            14.3.3. Hand Osteoarthritis

        14.4. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

            14.4.1. Animal

            14.4.2. Non-animal

        14.5. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            14.5.1. Hospital Pharmacies

            14.5.2. Retail Pharmacies

            14.5.3. Online Pharmacies

        14.6. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Latin America Viscosupplementation Market Attractiveness Analysis

            14.7.1. By Product Type

            14.7.2. By Application

            14.7.3. By Source

            14.7.4. By Distribution Channel 

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Viscosupplementation Market Analysis and Forecast

        15.1. Introduction

        15.2. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            15.2.1. Single Injection

            15.2.2. Three Injections

            15.2.3. Five Injections

        15.3. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

            15.3.1. Knee Osteoarthritis

            15.3.2. Hip Osteoarthritis

            15.3.3. Hand Osteoarthritis

        15.4. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

            15.4.1. Animal

            15.4.2. Non-animal

        15.5. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            15.5.1. Hospital Pharmacies

            15.5.2. Retail Pharmacies

            15.5.3. Online Pharmacies

        15.6. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Israel

            15.6.4. Rest of Middle East & Africa

        15.7. Middle East & Africa Viscosupplementation Market Attractiveness Analysis

            15.7.1. By Product Type

            15.7.2. By Application

            15.7.3. By Source

            15.7.4. By Distribution Channel 

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Competition Matrix

        16.2. Market Share Analysis, by Company, 2018

        16.3. Company Profiles

            16.3.1. Sanofi 

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Company Financials

                16.3.1.3. Growth Strategies

                16.3.1.4. SWOT Analysis

            16.3.2. Anika Therapeutics, Inc. 

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Company Financials

                16.3.2.3. Growth Strategies

                16.3.2.4. SWOT Analysis

            16.3.3. Zimmer Biomet Holdings, Inc. 

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Company Financials

                16.3.3.3. Growth Strategies

                16.3.3.4. SWOT Analysis

            16.3.4. Ferring B.V. 

                16.3.4.1. Company Overview (HQ, Business Segments)

                16.3.4.2. Growth Strategies

                16.3.4.3. SWOT Analysis

            16.3.5. Chugai Pharmaceutical Co., Limited

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Company Financials

                16.3.5.3. Growth Strategies

                16.3.5.4. SWOT Analysis

            16.3.6. Bioventus, Inc.

                16.3.6.1. Company Overview (HQ, Business Segments)

                16.3.6.2. Growth Strategies

                16.3.6.3. SWOT Analysis

            16.3.7. Labrha International 

                16.3.7.1. Company Overview (HQ, Business Segments)

                16.3.7.2. Growth Strategies

                16.3.7.3. SWOT Analysis

            16.3.8. Seikagaku Corporation 

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Company Financials

                16.3.8.3. Growth Strategies

                16.3.8.4. SWOT Analysis

            16.3.9. LG Chem 

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Company Financials

                16.3.9.3. Growth Strategies

                16.3.9.4. SWOT Analysis

    List of Tables

    Table 01: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 02: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 03: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

    Table 04: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 05: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 06: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 07: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 08: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

    Table 09: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 10: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 11: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 12: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 13: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

    Table 14: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 15: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 16: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 17: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 18: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

    Table 19: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 20: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 21: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 22: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 23: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

    Table 24: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 25: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 26: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 27: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 28: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027

    Table 29: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 30: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

    List of Figures

    Figure 01: Global Viscosupplementation Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

    Figure 02: Global Viscosupplementation Market Value (US$ Mn) Forecast, 2017–2027

    Figure 03: Global Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 04: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Single Injection, 2017–2027

    Figure 05: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Three Injections, 2017–2027

    Figure 06: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Five Injections, 2017–2027

    Figure 07: Global Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

    Figure 08: Global Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

    Figure 09: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Knee Osteoarthritis, 2017–2027

    Figure 10: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hip Osteoarthritis, 2017–2027

    Figure 11: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hand Osteoarthritis, 2017–2027

    Figure 12: Global Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

    Figure 13: Global Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

    Figure 14: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Animal, 2017–2027

    Figure 15: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-animal, 2017–2027

    Figure 16: Global Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

    Figure 17: Global Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 18: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017–2027

    Figure 19: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017–2027

    Figure 20: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017–2027

    Figure 21: Global Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

    Figure 22: Global Viscosupplementation Market Value Share Analysis, by Region, 2018 and 2027

    Figure 23: Global Viscosupplementation Market Attractiveness Analysis, by Region, 2019–2027

    Figure 24: North America Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 25: North America Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 26: North America Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

    Figure 27: North America Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

    Figure 28: North America Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

    Figure 29: North America Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

    Figure 30: North America Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

    Figure 31: North America Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 32: North America Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

    Figure 33: North America Viscosupplementation Market Value Share Analysis, by Country, 2018 and 2027

    Figure 34: North America Viscosupplementation Market Attractiveness Analysis, by Country, 2019–2027

    Figure 35: Europe Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 36: Europe Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 37: Europe Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

    Figure 38: Europe Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

    Figure 39: Europe Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

    Figure 40: Europe Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

    Figure 41: Europe Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

    Figure 42: Europe Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 43: Europe Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

    Figure 44: Europe Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 45: Europe Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 46: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 47: Asia Pacific Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 48: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

    Figure 49: Asia Pacific Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

    Figure 50: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

    Figure 51: Asia Pacific Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

    Figure 52: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

    Figure 53: Asia Pacific Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 54: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

    Figure 55: Asia Pacific Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 56: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 57: Latin America Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 58: Latin America Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 59: Latin America Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

    Figure 60: Latin America Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

    Figure 61: Latin America Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

    Figure 62: Latin America Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

    Figure 63: Latin America Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

    Figure 64: Latin America Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 65: Latin America Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

    Figure 66: Latin America Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 67: Latin America Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 68: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 69: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 70: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027

    Figure 71: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027

    Figure 72: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027

    Figure 73: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027

    Figure 74: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027

    Figure 75: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 76: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027

    Figure 77: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 78: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027 

Copyright © Transparency Market Research, Inc. All Rights reserved